종양 절제 시장 규모, 점유율, 성장 분석 : 최종사용자별, 용도별, 지역별 - 업계 예측(2026-2033년)

Tumor Ablation Market size was valued at USD 2.17 Billion in 2024 and is poised to grow from USD 2.48 Billion in 2025 to USD 7.17 Billion by 2033, growing at a CAGR of 14.2% during the forecast period (2026-2033).

The increasing global prevalence of cancer, combined with a growing preference for minimally invasive treatment options, is driving demand for tumor ablation procedures. Innovations in ablation technologies are set to unlock new avenues for providers, while the rising trend of utilizing outpatient facilities and the popularity of combination therapies will likely enhance the market for tumor ablation products. The escalating demand for advanced cancer treatments and heightened investments in oncology research are creating further business opportunities within this sector. Low to middle-income countries present significant potential due to a rapid uptick in cancer cases. However, challenges such as high equipment costs, competition from traditional treatments, and limited awareness in developing regions may hinder long-term market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Tumor Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Tumor Ablation Market Segments Analysis

Global Tumor Ablation Market is segmented by Technology, Treatment, Application, End User and region. Based on Technology, the market is segmented into Radiofrequency, Microwave, Irreversible Electroporation and Cryoablation. Based on Treatment, the market is segmented into Surgical Ablation, Percutaneous Ablation and Laparoscopic Ablation. Based on Application, the market is segmented into Lung Cancer, Kidney Cancer and Liver Cancer. Based on End User, the market is segmented into Hospitals and Clinics and Specialty Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Tumor Ablation Market

The rising global prevalence of cancer significantly contributes to the growing demand for tumor ablation procedures. This minimally invasive treatment is increasingly favored for managing liver, lung, and kidney cancers, particularly among patients who are not candidates for traditional surgical options. As the incidence of cancer continues to escalate, the need for effective and less invasive treatment alternatives like tumor ablation becomes even more critical, thereby boosting its market potential. The ability to provide targeted therapy with reduced recovery time makes tumor ablation an attractive option for both medical professionals and patients alike.

Restraints in the Tumor Ablation Market

The tumor ablation market faces significant challenges due to the high costs associated with tumor ablation equipment, which typically employs advanced technologies. These elevated prices contribute to the overall expense of treatment, making it difficult for healthcare facilities with constrained budgets to access and implement these essential tools. As a result, the financial burden of tumor ablation devices serves as a considerable barrier, limiting market growth and accessibility for various healthcare settings. This economic constraint fundamentally impacts the ability of providers to offer innovative treatment options, ultimately hindering advancements in the tumor ablation market.

Market Trends of the Tumor Ablation Market

The tumor ablation market is increasingly trending towards the integration of advanced imaging guidance technologies, which enhance procedural accuracy and improve patient outcomes. The utilization of real-time imaging modalities such as MRI, CT, and ultrasound is becoming essential, as these technologies enable clinicians to visualize tumor locations with precision, thereby minimizing complications and elevating success rates in ablation procedures. As the demand for minimally invasive treatments rises, companies in the sector are expected to prioritize research and development in imaging technologies, ultimately transforming patient care and solidifying their competitive edge in the evolving landscape of cancer treatment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Tumor Ablation Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Radiofrequency
• Microwave
• Irreversible Electroporation
• Cryoablation

Global Tumor Ablation Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Surgical Ablation
• Percutaneous Ablation
• Laparoscopic Ablation

Global Tumor Ablation Market Size by Application & CAGR (2026-2033)

• Market Overview
• Lung Cancer
• Kidney Cancer
• Liver Cancer

Global Tumor Ablation Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Specialty Centers

Global Tumor Ablation Market Size & CAGR (2026-2033)

• North America (Technology, Treatment, Application, End User)
  • US
  • Canada
• Europe (Technology, Treatment, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Treatment, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Treatment, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Treatment, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EDAP TMS S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IceCure Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galil Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ConMed Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuwave Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SonaCare Medical LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mermaid Medical A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations